These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14506995)

  • 1. Antibody deposition in rat heart which develops transplant vasculopathy in (donor x recipient) F1 environment.
    Li Z; Kitagawa-Sakakida S; Horiguchi K; Tori M; Shirakura R
    Surg Today; 2003; 33(7):509-17. PubMed ID: 14506995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial T-cell activation required for transplant vasculopathy in retransplanted rat cardiac allografts.
    Tori M; Kitagawa-Sakakida S; Li Z; Izutani H; Horiguchi K; Ito T; Matsuda H; Shirakura R
    Transplantation; 2000 Sep; 70(5):737-46. PubMed ID: 11003350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray-based gene expression profiling of retransplanted rat cardiac allografts that develop cardiac allograft vasculopathy.
    Kitagawa-Sakakida S; Fukushima N; Sawa Y; Horiguchi K; Doi T; Shirakura R; Matsuda H
    J Heart Lung Transplant; 2005 Dec; 24(12):2068-74. PubMed ID: 16364851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active cell migration in retransplanted rat cardiac allografts during the course of chronic rejection.
    Kitagawa-Sakakida S; Tori M; Li Z; Horiguchi K; Izutani H; Matsuda H; Shirakura R
    J Heart Lung Transplant; 2000 Jun; 19(6):584-90. PubMed ID: 10867339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of endothelin-converting enzyme attenuates transplant vasculopathy and rejection in rat cardiac allografts.
    Simonson MS; Herman WH; Robinson A; Schulak J; Hricik DE
    Transplantation; 1999 Jun; 67(12):1542-7. PubMed ID: 10401760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective chemokine and receptor gene expressions in allografts that develop transplant vasculopathy.
    Horiguchi K; Kitagawa-Sakakida S; Sawa Y; Li ZZ; Fukushima N; Shirakura R; Matsuda H
    J Heart Lung Transplant; 2002 Oct; 21(10):1090-100. PubMed ID: 12398874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of differentially expressed genes in rat aortic allograft vasculopathy.
    Chen J; Myllärniemi M; Akyürek LM; Häyry P; Marsden PA; Paul LC
    Am J Pathol; 1996 Aug; 149(2):597-611. PubMed ID: 8701998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ detection of tissue factor within the coronary intima in rat cardiac allograft vasculopathy.
    Hölschermann H; Bohle RM; Zeller H; Schmidt H; Stahl U; Fink L; Grimm H; Tillmanns H; Haberbosch W
    Am J Pathol; 1999 Jan; 154(1):211-20. PubMed ID: 9916935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiomyocyte-targeted HIF-1alpha gene therapy inhibits cardiomyocyte apoptosis and cardiac allograft vasculopathy in the rat.
    Keränen MA; Nykänen AI; Krebs R; Pajusola K; Tuuminen R; Alitalo K; Lemström KB
    J Heart Lung Transplant; 2010 Sep; 29(9):1058-66. PubMed ID: 20580263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic activation of integrin alphaVbeta3 in donors with spontaneous intracerebral hemorrhage is associated with subsequent development of vasculopathy in the heart transplant recipient.
    Yamani MH; Cook DJ; Tuzcu EM; Paul P; Ratliff NB; Yu Y; Hobbs R; Rincon G; Bott-Silverman C; Smedira N; Young JB; Starling RC
    J Heart Lung Transplant; 2005 Aug; 24(8):1014-8. PubMed ID: 16102435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of endothelin-1 mRNA and peptide expression in rat cardiac allografts with rejection and arteriosclerosis.
    Watschinger B; Sayegh MH; Hancock WW; Russell ME
    Am J Pathol; 1995 May; 146(5):1065-72. PubMed ID: 7747801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin inhibits transplant vasculopathy in long-surviving rat heart allografts.
    Schmid C; Heemann U; Azuma H; Tilney NL
    Transplantation; 1995 Oct; 60(7):729-33. PubMed ID: 7570985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recipient origin of neointimal vascular smooth muscle cells in cardiac allografts with transplant arteriosclerosis.
    Hillebrands J; van den Hurk BM; Klatter FA; Popa ER; Nieuwenhuis P; Rozing J
    J Heart Lung Transplant; 2000 Dec; 19(12):1183-92. PubMed ID: 11124488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retransplantation reverses mononuclear infiltration but not myointimal proliferation in a rat model of chronic cardiac allograft rejection.
    Schmid C; Heemann U; Tilney NL
    Transplantation; 1996 Jun; 61(12):1695-9. PubMed ID: 8685945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AP-1 and STAT-1 decoy oligodeoxynucleotides attenuate transplant vasculopathy in rat cardiac allografts.
    Stadlbauer TH; Wagner AH; Hölschermann H; Fiedel S; Fingerhuth H; Tillmanns H; Bohle RM; Hecker M
    Cardiovasc Res; 2008 Sep; 79(4):698-705. PubMed ID: 18511434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
    Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
    Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term allograft acceptance induced by single dose anti-leukocyte common antigen (RT7) antibody in the rat.
    Ko S; Jager MD; Tsui TY; Deiwick A; Dinkel A; Rohde F; Dahlke MH; Lauth O; Wonigeit K; Schlitt HJ
    Transplantation; 2001 Apr; 71(8):1124-31. PubMed ID: 11374414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irreversible chronic vascular rejection occurs only after development of advanced allograft vasculopathy: a comparative study of a rat cardiac allograft model using a retransplantation protocol.
    Forbes RD; Zheng SX; Gomersall M; Guttmann RD
    Transplantation; 1997 Mar; 63(5):743-9. PubMed ID: 9075848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel immunomodulator KRP-203 combined with cyclosporine prolonged graft survival and abrogated transplant vasculopathy in rat heart allografts.
    Takahashi M; Shimizu H; Murakami T; Enosawa S; Suzuki C; Takeno Y; Hakamata Y; Kudou S; Izawa S; Yasue T; Kobayashi E
    Transplant Proc; 2005; 37(1):143-5. PubMed ID: 15808575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of allograft inflammatory factor-1 is a marker of activated human vascular smooth muscle cells and arterial injury.
    Autieri MV; Carbone C; Mu A
    Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1737-44. PubMed ID: 10894811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.